Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) just unveiled an announcement.
Sihuan Pharmaceutical Holdings Group Ltd. has announced amendments to the terms of reference for its Nomination Committee, which was initially established in 2010. The committee is responsible for reviewing the board’s structure and composition, ensuring it aligns with the company’s corporate strategy. The changes aim to enhance governance by ensuring a diverse and independent board, which could impact the company’s strategic direction and stakeholder confidence.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. is a company incorporated in Bermuda, operating in the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services.
Average Trading Volume: 114,359,493
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.44B
For an in-depth examination of 0460 stock, go to TipRanks’ Overview page.